EUVIMEDEUVIMED entdecken
Crossref

Feasibility of Shallow Whole‐Genome Sequencing‐Based Circulating Tumour DNA Analysis in Canine Multicentric Lymphoma: A Pilot Study

Gyu-Hyun Kim iD, Jin-Hee Jang iD, Se-Hoon Kim iD, Min-Ok Ryu iD, Chang-Hyuk Kwon, Kyoung-Won Seo iD

Veterinary and Comparative Oncology · 03.11.2026

DOI: 10.1111/vco.70129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, online erschienen am 03.11.2026. Verfasst von Gyu-Hyun Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Science, College of Veterinary Medicine, Seoul National University, Seo…. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymphoma is a common canine malignancy with high morbidity and variable prognosis. Circulating tumour DNA (ctDNA) has emerged as a minimally invasive biomarker for tumour burden, treatment response and prognosis in human lymphoma. However, the feasibility of applying shallow whole‐genome sequencing (sWGS)‐based ctDNA analysis to canine lymphoma remains unclear. In this pilot study, plasma cell‐free DNA (cfDNA) was quantitatively assessed and additional genomic features were evaluated using sWGS in dogs with multicentric lymphoma. cfDNA concentration was significantly higher in dogs with lymphoma ( n = 13) compared with healthy controls ( n = 24) (median 3.18 vs. 0.25 ng/mL; Mann–Whitney U test, p = 0.004). However, total cfDNA concentration was not significantly associated with time to progression (TTP) ( p = 0.055). Tumour fraction (TF), a surrogate for ctDNA, showed preliminary association with clinical outcome, with a shorter median TTP in the high‐TF group than in the low‐TF group (77 vs. 302 days; p = 0.006). Genomic analysis further revealed copy number aberrations (CNAs); notably, gains on chromosome 13 containing the MYC locus were identified in three dogs, all of which belonged to the high‐TF group. Dogs with lymphoma also displayed distinct cfDNA fragmentation profiles, characterized by an enrichment of shorter fragments within the analysed size range and a shift in the highest mean‐profile peak compared with healthy controls. These findings demonstrate the feasibility of sWGS‐based cfDNA analysis in canine lymphoma and suggest that TF may provide clinically relevant information beyond total cfDNA concentration. Validation in a substantially larger, independent cohort is warranted.

Schlagwörter

Stichwörter der Autor:innen

DNA fragmentationcell‐free DNAcopy number aberrationliquid biopsy

Autor:innen und Institutionen

  • Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Science, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
  • GenesisEgo, Seoul, Republic of Korea.

ORCID-Profile: Gyu-Hyun Kim, Jin-Hee Jang, Se-Hoon Kim, Min-Ok Ryu, Kyoung-Won Seo

Zitieren

APA

Kim, G. H., Jang, J. H., Kim, S. H., Ryu, M. O., Kwon, C. H., & Seo, K. W. (2026). Feasibility of Shallow Whole‐Genome Sequencing‐Based Circulating Tumour DNA Analysis in Canine Multicentric Lymphoma: A Pilot Study. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.70129

Vancouver

Kim GH, Jang JH, Kim SH, Ryu MO, Kwon CH, Seo KW. Feasibility of Shallow Whole‐Genome Sequencing‐Based Circulating Tumour DNA Analysis in Canine Multicentric Lymphoma: A Pilot Study. Veterinary and Comparative Oncology. 2026. doi:10.1111/vco.70129

BibTeX
@article{Kim2026,
  author = {Kim, Gyu-Hyun and Jang, Jin-Hee and Kim, Se-Hoon and Ryu, Min-Ok and Kwon, Chang-Hyuk and Seo, Kyoung-Won},
  title = {Feasibility of Shallow Whole‐Genome Sequencing‐Based Circulating Tumour DNA Analysis in Canine Multicentric Lymphoma: A Pilot Study},
  journal = {Veterinary and Comparative Oncology},
  year = {2026},
  doi = {10.1111/vco.70129}
}
Kostenlos starten →